A Tetracycline Controlled Activation/Repression System with Increased Potential for Gene Transfer into Mammalian Cells

Journal of Gene Medicine

Volumn 1, Issue 1, 1999, Pages 4-12

  Freundlieb, Sabine ^a   Schirra Müller, Christiane ^a   Bujard, Hermann ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Gene expression; Regulation; Tetracycline

Indexed keywords

MAMMALIA;

LUCIFERASE; PRIMER DNA; TETRACYCLINE; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; CELL LINE; CELL STRAIN 3T3; CELL STRAIN COS1; DRUG EFFECT; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; MOLECULAR CLONING; MOUSE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REPORTER GENE;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; COS CELLS; DNA PRIMERS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HELA CELLS; HUMANS; LUCIFERASES; MICE; PROMOTER REGIONS (GENETICS); TETRACYCLINE; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0032600013     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y     Document Type: Article

References (26)

1. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992; 89: 5547-5551.
2. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
3. Freundlieb S, Baron U, Bonin AL, Gossen M, Bujard H. Use of tetracycline-controlled gene expression systems to study mammalian cell cycle. Methods Enzymol 1997; 283: 159-173.
4. Weinmann P, Gossen M, Hillen W, Bujard H, Gatz C. A chimeric transactivator allows tetracycline-responsive gene expression in whole plants. Plant J 1994; 5: 559-569.
5. Gari E, Piedrafita L, Aldea M, Herrero E. A set of vectors with a tetracycline-regulatable promoter system for modulated gene expression in Saccharomyces cerevisiae. Yeast 1997; 13: 837-848.
6. Girard F, Bello B, Laemmli UK, Gehring WJ. In vivo analysis of scaffold-associated regions in Drosophila: a synthetic high-affinity SAR binding protein suppresses position effect variegation. Embo J 1998; 17: 2079-2085.
7. Bieschke ET, Wheeler JC, Tower J. Doxycycline-induced transgene expression during Drosophila development and aging. Mol Gen Genet 1998; 258: 571-579.
8. Kistner A, Gossen M, Zimmermann F, et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 1996; 93: 10933-10938.
9. Efrat S, Fusco DeMane D, Lemberg H, al Emran O, Wang X. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci U S A 1995; 92: 3576-3580.
10. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER. Control of memory formation through regulated expression of a CaMKII transgene. Science 1996; 274: 1678-1683.
11. Ewald D, Li M, Efrat S, et al. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 1996; 273: 1384-1386.
12. Fishman GI, Kaplan ML, Buttrick PM. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest 1994; 93: 1864-1868.
13. Harding TC, Geddes BJ, Murphy D, Knight D, Uney JB. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat Biotechnol 1998; 16: 553-555.
14. Yin DX, Zhu L, Schimke RT. Tetracycline-controlled gene expression system achieves high-level and quantitative control of gene expression. Anal Biochem 1996; 235: 195-201.
15. Lee P, Morley G, Huang Q, et al. Conditional lineage ablation to model human diseases. Proc Natl Acad Sci U S A 1998; 95: 11371-11376.
16. Gossen M, Bonin AL, Bujard H. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem Sci 1993; 18: 471-475.
17. Deuschle U, Meyer WK, Thiesen HJ. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol 1995; 15: 1907-1914.
18. Witzgall R, O'Leary E, Leaf A, Onaldi D, Bonventre JV. The Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc Natl Acad Sci U S A 1994; 91: 4514-4518.
19. Baron U, Gossen M, Bujard H. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 1997; 25: 2723-2729.
20. Vara JA, Portela A, Ortin J, Jimenez A. Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance. Nucleic Acids Res 1986; 14: 4617-4624.
21. Martin B, Renkawitz R, Muller M. Two silencing sub-domains of v-erbA synergize with each other, but not with RXR. Nucleic Acids Res 1994; 22: 4899-4905.
22. Han K, Manley JL. Transcriptional repression by the Drosophila even-skipped protein: definition of a minimal repression domain. Genes Dev 1993; 7: 491-503.
23. Boshart M, Weber F, Jahn G, Dorsch-Hasler K, Fleckenstein B, Schaffher W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985; 41: 521-530.
24. Baron U, Schnappinger D, Helbl V, Gossen M, Hillen W, Bujard H. Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc Natl Acad Sci U S A 1999 (In Press).
25. Bohl D, Naffakh N, Heard JM. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med 1997; 3: 299-305.
26. Kalderon D, Roberts BL, Richardson WD, Smith AE. A short amino acid sequence able to specify nuclear location. Cell 1984; 39: 499-509.